Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Annual Review of Biomedical Data Science is Scopus-indexed (Q1, CiteScore 11.6), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Annual Reviews Inc..
Checked against the index lists dated .
ISSN 2574-3414Verify ISSN ↗
Publisher: Annual Reviews Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (miscellaneous) | 10 / 144 | 93rd | Q1 |
| Genetics | 27 / 357 | 92nd | Q1 |
| Biomedical Engineering | 50 / 342 | 85th | Q1 |
| Cancer Research | 37 / 233 | 84th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q1, CiteScore 11.6.
Annual Review of Biomedical Data Science is Q1 in Biochemistry, Genetics and Molecular Biology (miscellaneous) (rank 10 of 144), Q1 in Genetics (rank 27 of 357) and Q1 in Biomedical Engineering (rank 50 of 342), by CiteScore 2025. It is ranked in 4 subject areas in all.
Annual Review of Biomedical Data Science is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 11.6, which places it in quartile Q1 at the 93rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.626, quartile Q1, with an H-index of 33.
Annual Review of Biomedical Data Science is published by Annual Reviews Inc. Its ISSN is 2574-3414.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Annual Review of Biomedical Data Science has an h-index of 43 and a 2-year mean of 10.3 citations per paper (OpenAlex). Its Scopus CiteScore is 11.6, quartile Q1. On 2-year citations it ranks #2 of 141 Scopus journals in Biochemistry, Genetics and Molecular Biology (miscellaneous).
Annual Review of Biomedical Data Science published 28 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2022–2026), authors are most often from United States (67.7%), United Kingdom (5.9%) and Australia (2.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.